Association of ovary-sparing hysterectomy with ovarian reserve

Obstetrics and Gynecology

Volumn 127, Issue 5, 2016, Pages 819-827

  Trabuco, Emanuel C ^a,b   Moorman, Patricia G ^a,b   Algeciras Schimnich, Alicia ^a,b   Weaver, Amy L ^a,b   Cliby, William A ^a,b  

^a Mayo Clinic   (Mongolia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; OVARIAN RESERVE; OVARY FUNCTION; OVARY SPARING HYSTERECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RACE DIFFERENCE; SECONDARY ANALYSIS; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PROCEDURES;

ADULT; ANTI-MULLERIAN HORMONE; COHORT STUDIES; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN RESERVE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 84964049808     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001398     Document Type: Article

References (29)

1. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005;106:219-26.
2. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-83.
3. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, et al. Increased risk of parkin-sonism in women who underwent oophorectomy before menopause. Neurology 2008;70:200-9.
4. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ III. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006;7:821-8.
5. Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008;14:111-6.
6. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009;113:1027-37.
7. Keshavarz H, Hillis H, Kieke BA, Marchbanks P. Hysterectomy surveillance-United States, 1994-1999. Atlanta (GA): Centers for Disease Control and Prevention; 2002. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5105a1.htm. Retrieved May 1, 2012.
8. Ahn EH, Bai SW, Song CH, Kim JY, Jeong KA, Kim SK, et al. Effect of hysterectomy on conserved ovarian function. Yonsei Med J 2002;43:53-8.
9. Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG 2005;112:956-62.
10. Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol 2011;118:1271-9.
11. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:34.e1-7.
12. Moorman PG, Schildkraut JM, Myers ER, Wang F. Reported symptoms before and one year after hysterectomy in African American and white women. J Womens Health (Larchmt) 2011;20:1035-42.
13. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603-12.
14. Vigier B, Picard JY, Tran D, Legeai L, Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984;114:1315-20.
15. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-83.
16. La Marca A, De Leo V, Giulini S, Orvieto R, Malmusi S, Giannella L, et al. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig 2005;12:545-8.
17. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129-34.
18. Sowers M, McConnell D, Gast K, Zheng H, Nan B, McCarthy JD, et al. Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril 2010; 94:1482-6.
19. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007;115:2340-3.
20. Kaiser L. Adjusting for baseline: change or percentage change? Stat Med 1989;8:1183-90.
21. Lee DY, Park HJ, Kim BG, Bae DS, Yoon BK, Choi D. Change in the ovarian environment after hysterectomy as assessed by ovarian arterial blood flow indices and serum anti-Müllerian hormone levels. Eur J Obstet Gynecol Reprod Biol 2010;151: 82-5.
22. Petri Nahás EA, Pontes A, Nahas-Neto J, Borges VT, Dias R, Traiman P. Effect of total abdominal hysterectomy on ovarian blood supply in women of reproductive age. J Ultrasound Med 2005;24:169-74.
23. Chalmers C. Does hysterectomy in a premenopausal woman affect ovarian function? Med Hypotheses 1996;46:573-5.
24. Xiangying H, Lili H, Yifu S. The effect of hysterectomy on ovarian blood supply and endocrine function. Climacteric 2006;9:283-9.
25. Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 2007;22:1996-2005.
26. Atabekoglu C, Taşkin S, Kahraman K, Gemici A, Taskin EA, Ozmen B, et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: a pilot study. Climacteric 2012;15:393-7.
27. Seifer DB, Zackula R, Grainger DA; Society for Assisted Reproductive Technology Writing Group Report. Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. Fertil Steril 2010;93:626-35.
28. Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, Watts DH, et al. Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 2009;92:1674-8.
29. Sessums JV, Murphy DP. The influence of endometrium upon the rabbit ovary after hysterectomy. Surg Gynecol Obstet 1933; 56:600-9.